Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease.

Inflammatory bowel diseases(2023)

引用 0|浏览8
暂无评分
摘要
Efficacy and safety of anti-TNFs in VEOIBD is comparable to what has previously been reported in older patients.
更多
查看译文
关键词
very early onset inflammatory bowel disease, monogenic, adalimumab, infliximab, whole exome sequencing
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要